Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulised rt-PA for COVID-19 ARDS
NCT04356833Phase 2Completed
- Sponsor
- University College London
- Start
- Apr 2020
- Primary completion
- Mar 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of tissue-plasminogen activator in acute respiratory distress syndrome (ARDS), sponsored by University College London. Started Apr 2020; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04356833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04356833.